Name | KBP-5074 |
---|
Description | KBP-5074 (KBP5074) is a novel non-steroidal, highly selective mineralocorticoid receptor antagonist for the treatment of hypertensive chronic kidney disease. Other Indication Phase 2 Clinical |
---|---|
References | References 1. Granberg K, et al. J Med Chem. 2018 Dec 31. doi: 10.1021/acs.jmedchem.8b01523. View Related Products by Target Mineralocorticoid Receptor (MLR) Other Indication |
Molecular Formula | C28H30ClN5O2 |
---|---|
Molecular Weight | 504.031 |